Veterinary Dermatology Drugs Market Growth Outlook Through 2024-2033

Overview and Scope
Veterinary dermatology drugs refer to the drugs used to treat dermatological disorders in animals that are suffering from skin diseases such as bacterial and fungal infections.

Sizing and Forecast
The veterinary dermatology drugs market size has grown rapidly in recent years. It will grow from $7.75  billion in 2023 to $8.67  billion in 2024 at a compound annual growth rate (CAGR) of 11.9%.  The  growth in the historic period can be attributed to prevalence of dermatological conditions, increased veterinary spending, changing environmental factors, companion animal healthcare awareness, regulatory approvals, zoonotic disease awareness..

The veterinary dermatology drugs market size is expected to see rapid growth in the next few years. It will grow to $13.42  billion in 2028 at a compound annual growth rate (CAGR) of 11.5%.  The growth in the forecast period can be attributed to growing pet insurance adoption, rising incidence of allergies, globalization of pet products, holistic pet care approach, companion animal population growth, consumer education.. Major trends in the forecast period include advancements in veterinary dermatology research, focus on allergy management, demand for topical treatments, nutraceuticals and dermatological health, telemedicine in veterinary dermatology, customized and personalized therapies, pet insurance and healthcare spending..

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/veterinary-dermatology-drugs-global-market-report

Segmentation & Regional Insights
The veterinary dermatology drugs market covered in this report is segmented –
1) By Product Type: Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs
2) By Animal Type: Companion Animal, Livestock Animal
3) By Drug Indication: Parasitic Infections, Allergic Infections, Other Indications
4) By Route of Administration: Topical, Injectable, Oral
5) By Distribution Channel: Retail, Hospital Pharmacies, Online

North America was the largest region in the veterinary dermatology drugs market in 2023. Asia-Pacific is expected to be the fastest-growing region in the veterinary dermatology drugs market report forecast period. The regions covered in the veterinary dermatology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8025&type=smp

Major Driver Impacting Market Growth
The increase number of pet owners is expected to propel the growth of the veterinary dermatology drugs market going forward. Pet owners are individuals who own or adopt a pet animal. Pet owners take care of their pets and their health, thus providing necessary health facilities to the pets, which increases the demand for veterinary drugs. For instance, in 2021, according to a national poll by the American Society for the Prevention of Cruelty to Animals (ASPCA), a US-based non-profit organization working to prevent animal cruelty, out of all the respondents, one in five households had a cat or dog from the beginning of the COVID-19 crisis, which accounted for 23 million households. 90% of dogs and 85% of cats were still in their adopted homes, and the households were not considering abandoning them again. Therefore, the increasing number of pet owners is driving the veterinary dermatology drugs market.

Key Industry Players
Major companies operating in the veterinary dermatology drugs market report are Elanco Animal Health Inc., Merk & Co. Inc., Zoetis Inc., Vetoquinol SA, Ceva Santé Animale, Virbac S.A., Bioibérica S.A.U., Bimeda Inc., Indian Immunologicals Ltd., Vivaldis Health and Fodds Pvt Ltd., IDEXX Laboratories Inc., Eli Lilly and Company, SavaVet, Toray Industries Inc., AB Science, Merial, Vetmedica, Mars Incorporated, Leti Pharma, Bioiberica S.A.U, Kindred Biosciences, Bayer Animal Health, Boehringer Ingelheim Vetmedica, Dechra Pharmaceuticals PLC, Norbrook Laboratories Limited, Kyoritsu Seiyaku Corporation, Veterinary Centers of America Inc., Heska Corporation, Biogénesis Bagó, Nexvet, Aratana Therapeutics

The veterinary dermatology drugs market report table of contents includes:
1. Executive Summary

2. Veterinary Dermatology Drugs Market Characteristics
3. Veterinary Dermatology Drugs Market Trends And Strategies
4. Veterinary Dermatology Drugs Market – Macro Economic Scenario
5. Global Veterinary Dermatology Drugs Market Size and Growth
   .
   31. Global Veterinary Dermatology Drugs Market Competitive Benchmarking
6. Global Veterinary Dermatology Drugs Market Competitive Dashboard
7. Key Mergers And Acquisitions In The Veterinary Dermatology Drugs Market
8. Veterinary Dermatology Drugs Market Future Outlook and Potential Analysis
9. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model